Patients with indeterminate chronic hepatitis B (CHB) phase are at risk of progressing to advanced liver disease and hepatocellular carcinoma (HCC), according to study results published in the Journal ...
Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis alfapump® is the first US approved active implantable medical device (Class III) for ...
The discovery could lead to improved diagnosis and treatment of this growing ... which can lead to severe liver damage such as cirrhosis and liver cancer. MASLD is caused by overweight and obesity ...
enabling tailored treatments: Liver-Specific MASH: Focus on therapies to halt liver damage and prevent progression to cirrhosis or liver cancer. Cardiometabolic MASH: Emphasize aggressive ...